MPC-3100 is a selective inhibitor of mitochondrial complex I, classified within the biguanide derivatives, utilized primarily in research to investigate oxidative phosphorylation and metabolic disorders… Read more
MPC-3100 is a selective inhibitor of mitochondrial complex I, classified within the biguanide derivatives, utilized primarily in research to investigate oxidative phosphorylation and metabolic disorders by blocking electron transport at the ubiquinone reduction site. For laboratories engaged in pharmaceutical development, access to high-quality reference standards is essential for accurate analytical testing and method validation. The associated impurities, metabolites, and stable isotope-labelled standards provided in this category play a critical role in impurity profiling and quantitative analysis. These compounds allow researchers to precisely monitor degradation pathways and ensure regulatory compliance during the lifecycle of the parent drug. By utilizing these specialized materials, analytical chemists can conduct robust quality control and facilitate the characterization of complex metabolic profiles, supporting the overall integrity of the drug development process.